IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Journal of Cellular Neuroscience and Oxidative Stress
  • Volume:10 Issue:3
  • Experimental Parkinson’s disease models

Experimental Parkinson’s disease models

Authors : Eda Duygu IPEK
Pages : 795-795
Doi:10.37212/jcnos.610154
View : 19 | Download : 12
Publication Date : 2018-08-18
Article Type : Conference Paper
Abstract :Parkinson`s disease insert ignore into journalissuearticles values(PD); is a neurodegenerative  disease that develops slowly; however, there is no  efficient method of early diagnosis, nor is there a cure.  It is characterized by the relatively selective loss of  dopaminergic neuronal cells in the substantia nigra pars  compacta and the presence of alpha-synuclein  aggregation named as Lewy bodies and Lewy neurites  in surviving affected neurons. Nigrostriatal  dopaminergic neurodegeneration is shared with other  parkinsonian disorders, including some genetic forms of  parkinsonism, but many of these disorders do not have  Lewy bodies. An ideal animal model for PD, therefore,  should exhibit age-dependent and progressive  dopaminergic neurodegeneration, motor and non-motor  dysfunction, and abnormal alpha-synuclein pathology.  A wide range of neurotoxic agents are used to  induce PD, alterations that are similar with dose  observed in human PD. These agents are classified  mainly by administration route and the species involved.  The toxins that are mainly used in present 6-  hydroxydopamine, 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine, rotenone, paraquat, reserpine,  methamphetamine, 3-nitrotyrosine and isoquinoline  derivatives insert ignore into journalissuearticles values(Tieu, 2011; McDowell and Chesselet, 2012;  Bezard et al. 2013);. In addition, viral mediated  expression of human α-synuclein, as well as the  inoculation of pathogenic α-synuclein species from  Lewy bodies of PD patients, for accurately modelling  progressive self-propagating neurodegeneration and  genetic LRRK2 models insert ignore into journalissuearticles values(PARK8 gene mutation); has  been used insert ignore into journalissuearticles values(Jiang and Dickson, 2018);.  In conclusion, these models are only  approximations, each possibly holding a certain degree  of relevance. Thus, researchers should select models  whose characteristics are most suitable for addressing  the experimental question.
Keywords : Experimental Parkinsons disease, Neurotoxic agents

ORIGINAL ARTICLE URL
VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025